Somatic mutations and human breast cancer. A status report.
about
Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancerAnalysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancerTransgenic mouse models of human breast cancer.Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18.When considering attacks against the National Breast Screening Study, consider the sources.Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancerDifferential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomasp53 codon 72 polymorphism and breast cancer risk: A meta-analysis.Loss of heterozygosity on chromosome 11 q in breast cancerFrequent mutations in breast cancer.Growth suppression of normal mammary epithelial cells by wild-type p53.Tumourigenesis associated with the p53 tumour suppressor gene.Expression of E-Cadherin in breast carcinomas and its association with other biological markers - a prospective study.Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.Expression of the novel human gene, UBE2Q1, in breast tumors.Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells.Analysis of genetic alterations related to the development and progression of breast carcinoma.
P2860
Q24537686-F99CA9E0-AF9C-458A-AF81-AF4DA1BAA369Q24564525-81BD9DD1-E88B-429B-912D-3E735FCCE5F4Q24656704-C612ED6F-FCFF-43F7-B8DA-DE7172A701ECQ34130558-5688EA4A-3041-4049-A3BD-75894238293EQ34569408-A6D63305-7B5F-42C6-B178-C46B5DE20BD5Q34725735-AD3CF5D6-323B-48FA-85CF-6E90AE337691Q35745924-2660AFA9-900E-4CB8-96D7-C462B269FD6AQ35798514-DD94F756-3E08-4FDA-9DBA-D938442F2BE5Q35833680-4917C8E7-A54D-4CF1-A35B-34D9C4180688Q36900858-3C48138A-C3AC-4E32-8481-779C4A3F7927Q37261791-264826E9-900B-4780-98A9-157369C9666AQ40800279-772BF6A2-872B-43A0-9BA2-90E7B1583329Q41513447-FD8843F3-6F3E-480B-8226-0AA03496CBA7Q41809596-D1B2AA8C-C326-408C-A73C-0D2046274D5BQ41847937-9B4C1D32-C082-45C6-B9C9-ADC1C7CBF04EQ42557015-6AF2043A-E1AC-4966-93EA-E2E3AD94C787Q42628655-925F8497-42DB-4536-8147-39B36E3E98E1Q52180868-4B7E2AF7-5852-4830-9911-E6CF1544FA49Q55129606-ED9F11B6-4D62-4BC7-AFED-9D830BC367A4
P2860
Somatic mutations and human breast cancer. A status report.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Somatic mutations and human breast cancer. A status report.
@ast
Somatic mutations and human breast cancer. A status report.
@en
type
label
Somatic mutations and human breast cancer. A status report.
@ast
Somatic mutations and human breast cancer. A status report.
@en
prefLabel
Somatic mutations and human breast cancer. A status report.
@ast
Somatic mutations and human breast cancer. A status report.
@en
P2093
P2860
P1433
P1476
Somatic mutations and human breast cancer. A status report.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(19920315)69:6+<1582::AID-CNCR2820691313>3.0.CO;2-Y
P407
P433
P577
1992-03-01T00:00:00Z